The current PE ratio of ELAN can't be determined, as the TTM EPS of -$2.5 is negative. Elanco Animal Health's last PE ratio on record was 163.61 in December 2019.
The mean historical PE ratio of Elanco Animal Health over the last six years is 144.87. Over the past six years, ELAN's PE ratio was at its highest in the Mar 2019 quarter at 267.25, with a price of $32.07 and an EPS of $0.12. The Jun 2019 quarter recorded the bottom point at 78.6, with a price of $33.8 and an EPS of $0.43.
Maximum annual increase: 45.29% in 2019
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | 163.61 | 45.29% |
2018 | 112.61 | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
ORGO Organogenesis Holdings Inc | 62.25 | $328.59M |
OPTN OptiNose Inc | N/A | $113.78M |
OPK Opko Health Inc | N/A | $906.09M |
ELAN Elanco Animal Health Inc | N/A | $6.67B |
The current price to earnings ratio of ELAN can't be calculated, as its EPS of -$2.5 is negative.
In the last six years, the Mar 2019 quarter recorded the highest quarterly PE ratio at 267.25.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.